检索

标题
作者
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.
The effectiveness of the use of natural mineral water “Donat” in the complex therapy of lipid and carbohydrate metabolism disorders
Mubarakshina O., Elizarova I., Cherenkova O.
Treatment options for different subtypes of gestational diabetes
Davidenko I., Volkova N., Degtyareva Y.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E., Shinkin M., Morozova I.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.
Microcirculation disorders in diabetic patients
Zelenina T., Zemlianoi A., Salukhov V., Ismailov D.
Metabolic comorbidity of endometritis after caesarean section
Korobkov N., Bakulina N., Borovik N.
Glucometer with a mobile application as a system for remote control of diabetes
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M., Golubeva Y.
Features of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus hospitalized with coronavirus infection
Markova T., Anchutina A., Stas M., Medzhidova M.
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
Vereshchagin E., Svechnikova E., Arutyunyan G., Artemyeva N., Devyatova A., Sherf A.
Problems of pancreas transplantation and the role of bioengineered materials in long-term survival and functioning of islet cells
Bulgakova S., Sharonova L., Dolgikh Y., Kosareva O., Treneva E., Kurmaev D.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I., Boeva V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.
Modern technologies in diabetes management
Koteshkova O., Antsiferov M., Antsiferova D., Demidov N.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
Cohort study of clinical and anamnestic characteristics of patients with a combination of type 2 diabetes mellitus and irritable bowel syndrome
Suprun O., Bagriy A., Mikhailichenko E., Andreeva E., Evtushenko A., Suprun E.
Intensification of glucose-lowering therapy for type 2 diabetes mellitus using insulin degludec: clinical case analysis
Elsukova O.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N., Degtyareva E.
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
Kazimova A., Polukhova S.
Monogennye formy sakharnogo diabeta
Zubkova N., Tikhonovich Y., Tyul'pakov A.
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.
Intensification of diabetes therapy using insulin degludec. A series of atypical clinical cases
Smirnova E.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study
Farmanov A., Bublik E., Vinogradskaya O., Udovichenko O., Zilov A., Ryzhkova E., Egorov V., Fadeev V., Deunezheva S., Zhivov A., Tobianskaya I.
Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors
Zhurtova I., Aramisova L., Abdul Moati H., Arkhestova D., Khachmakhova E.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
Diabetes mellitus and new coronavirus infection: a look into the past; conclusions on prevention and treatment tactics for the future
Aramisova L., Zhurtova I., Gubachikova A.
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
Demicheva T.
Sulodexide: meta-analysis of the treatment of diabetic nephropathy and literature review
Novikova M., Koteshkova O., Antsiferov M.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O., Nikitina E., Chuprova A., Kaysina O.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.
Optimization of the diabetes screening questionnaire for patients with psoriasis
Morzhanaeva M., Svechnikova E.
Application of the diabetes screening questionnaire in patients with psoriasis
Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A., Valitov B., Chernikova N., Antsiferov M.
News of medicine
Kudinova S.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ametov A., Chernikova N., Demidova T., Nazhmutdinova P.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Antsiferov M., Demidov N.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
Statins and the risk of diabetes: an evidence-based review
Leonova M.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G., Antsiferov M., Alekseeva Y.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O., Sobolev A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N., Antsiferov M., Dorofeeva L.
Metabolic syndrome and intestinal microbiota
Egshatyan L., Mkrtumyan A., Zvenigorodskaya L.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M., Koteshkova O.
Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta
Meleshkevich T., Luchina E., Lukashova M.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII
Sharonova L., Verbovoy A., Sharonova D.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.
PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII
Gur'eva I., Svetlova O.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
Insulin pump - advanced menu of experienced user
Arbatskaya N., Arbatsraya N.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
Advance - movement forward
Petunina N., Petunina N.
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
Nikiforov V.
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A., Mikhailichenko E., Prikolota A., Mogilevskaya K.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Novikova M., Demidov N.
What should the practitioner remember when managing patients with diabetic neuropathy
Isakova E., Kotov S.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
Rujatkina L., Rujatkin D., Zemljanuhina S.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
Statiny i risk vozniknoveniya novykh sluchaev sakharnogo diabeta: sootnoshenie riska i pol'zy. Sovremennye predstavleniya o tselevykh urovnyakh lipidov u patsientov s sakharnym diabetom
Shalaev S., Safiullina Z., Mikhal'chuk N.
1 - 100 的 305 信息 1 2 3 4 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##